Related Experiment Video
Updated: May 14, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
Progressive loss of retinal ganglion cell function precedes structural loss by several years in glaucoma suspects
Michael R Banitt1, Lori M Ventura, William J Feuer
1Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida 33136, USA. mbanitt@med.miami.edu
Purpose:
We determined the time lag between loss of retinal ganglion cell function and retinal nerve fiber layer (RNFL) thickness.
Methods:
Glaucoma suspects were followed for at least four years. Patients underwent pattern electroretinography (PERG), optical coherence tomography (OCT) of the RNFL, and standard automated perimetry testing at 6-month intervals. Comparisons were made between changes in all testing modalities. To compare PERG and OCT measurements on a normalized scale, we calculated the dynamic range of PERG amplitude and RNFL thickness. The time lag between function and structure was defined as the difference in time-to-criterion loss between PERG amplitude and RNFL thickness.
Results:
For PERG (P < 0.001) and RNFL (P = 0.030), there was a statistically significant difference between the slopes corresponding to the lowest baseline PERG amplitude stratum (≤50%) and the reference stratum (>90%). Post hoc comparisons demonstrated highly significant differences between RNFL thicknesses of eyes in the stratum with most severely affected PERG (≤50%) and the two strata with least affected PERG (>70%). Estimates suggested that the PERG amplitude takes 1.9 to 2.5 years to lose 10% of its initial amplitude, whereas the RNFL thickness takes 9.9 to 10.4 years to lose 10% of its initial thickness. Thus, the time lag between PERG amplitude and RNFL thickness to lose 10% of their initial values is on the order of 8 years.
Conclusions:
In patients who are glaucoma suspects, PERG signal anticipates an equivalent loss of OCT signal by several years.
More Related Videos
Related Concept Videos
Glaucoma: Overview
Diabetic Retinopathy
Photoreceptors and Visual Pathways
Anatomy of the Eyeball
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

